DCP1A_HUMAN - dbPTM
DCP1A_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID DCP1A_HUMAN
UniProt AC Q9NPI6
Protein Name mRNA-decapping enzyme 1A
Gene Name DCP1A
Organism Homo sapiens (Human).
Sequence Length 582
Subcellular Localization Cytoplasm, P-body . Nucleus . Co-localizes with NANOS3 in the processing bodies (By similarity). Predominantly cytoplasmic, in processing bodies (PB) (PubMed:16364915). Nuclear, after TGFB1 treatment. Translocation to the nucleus depends on interacti
Protein Description Necessary for the degradation of mRNAs, both in normal mRNA turnover and in nonsense-mediated mRNA decay. Removes the 7-methyl guanine cap structure from mRNA molecules, yielding a 5'-phosphorylated mRNA fragment and 7m-GDP. Contributes to the transactivation of target genes after stimulation by TGFB1..
Protein Sequence MEALSRAGQEMSLAALKQHDPYITSIADLTGQVALYTFCPKANQWEKTDIEGTLFVYRRSASPYHGFTIVNRLNMHNLVEPVNKDLEFQLHEPFLLYRNASLSIYSIWFYDKNDCHRIAKLMADVVEEETRRSQQAARDKQSPSQANGCSDHRPIDILEMLSRAKDEYERNQMGDSNISSPGLQPSTQLSNLGSTETLEEMPSGSQDKSAPSGHKHLTVEELFGTSLPKEQPAVVGLDSEEMERLPGDASQKEPNSFLPFPFEQLGGAPQSETLGVPSAAHHSVQPEITTPVLITPASITQSNEKHAPTYTIPLSPVLSPTLPAEAPTAQVPPSLPRNSTMMQAVKTTPRQRSPLLNQPVPELSHASLIANQSPFRAPLNVTNTAGTSLPSVDLLQKLRLTPQHDQIQTQPLGKGAMVASFSPAAGQLATPESFIEPPSKTAAARVAASASLSNMVLAPLQSMQQNQDPEVFVQPKVLSSAIQVAGAPLVTATTTAVSSVLLAPSVFQQTVTRSSDLERKASSPSPLTIGTPESQRKPSIILSKSQLQDTLIHLIKNDSSFLSTLHEVYLQVLTKNKDNHNL
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
5Phosphorylation---MEALSRAGQEMS
---CHHHHHHHHHHH
27.4220068231
12PhosphorylationSRAGQEMSLAALKQH
HHHHHHHHHHHHHHC
17.6920068231
22PhosphorylationALKQHDPYITSIADL
HHHHCCCCHHHHHHH
23.9220068231
47UbiquitinationPKANQWEKTDIEGTL
CCCCCCEEECCCCEE
48.8422053931
48UbiquitinationKANQWEKTDIEGTLF
CCCCCEEECCCCEEE
30.6029967540
60PhosphorylationTLFVYRRSASPYHGF
EEEEEEECCCCCCCE
24.8928787133
62PhosphorylationFVYRRSASPYHGFTI
EEEEECCCCCCCEEE
27.5123401153
64PhosphorylationYRRSASPYHGFTIVN
EEECCCCCCCEEEEE
16.4528122231
68PhosphorylationASPYHGFTIVNRLNM
CCCCCCEEEEECCCC
28.7123403867
70UbiquitinationPYHGFTIVNRLNMHN
CCCCEEEEECCCCCC
2.8729967540
94UbiquitinationEFQLHEPFLLYRNAS
HHEECCCEEHHCCCC
7.1829967540
108UbiquitinationSLSIYSIWFYDKNDC
CEEEEEEEEECCCHH
4.6429967540
120AcetylationNDCHRIAKLMADVVE
CHHHHHHHHHHHHHH
36.1025953088
120UbiquitinationNDCHRIAKLMADVVE
CHHHHHHHHHHHHHH
36.1029967540
130PhosphorylationADVVEEETRRSQQAA
HHHHHHHHHHHHHHH
34.3626074081
133PhosphorylationVEEETRRSQQAARDK
HHHHHHHHHHHHHHC
24.2926074081
140UbiquitinationSQQAARDKQSPSQAN
HHHHHHHCCCHHHCC
47.31-
142PhosphorylationQAARDKQSPSQANGC
HHHHHCCCHHHCCCC
32.0526846344
143UbiquitinationAARDKQSPSQANGCS
HHHHCCCHHHCCCCC
28.1529967540
144PhosphorylationARDKQSPSQANGCSD
HHHCCCHHHCCCCCC
47.3626846344
150PhosphorylationPSQANGCSDHRPIDI
HHHCCCCCCCCCHHH
37.5426846344
156PhosphorylationCSDHRPIDILEMLSR
CCCCCCHHHHHHHHH
41.9432142685
157UbiquitinationSDHRPIDILEMLSRA
CCCCCHHHHHHHHHC
3.4829967540
160PhosphorylationRPIDILEMLSRAKDE
CCHHHHHHHHHCHHH
3.5532142685
162PhosphorylationIDILEMLSRAKDEYE
HHHHHHHHHCHHHHH
28.9623927012
168PhosphorylationLSRAKDEYERNQMGD
HHHCHHHHHHHCCCC
30.2628796482
168 (in isoform 2)Phosphorylation-30.2620068231
171 (in isoform 2)Phosphorylation-25.0120068231
174 (in isoform 2)Phosphorylation-25.9820068231
176PhosphorylationERNQMGDSNISSPGL
HHHCCCCCCCCCCCC
30.2721712546
179PhosphorylationQMGDSNISSPGLQPS
CCCCCCCCCCCCCCC
34.4330278072
180PhosphorylationMGDSNISSPGLQPST
CCCCCCCCCCCCCCH
21.1330278072
186PhosphorylationSSPGLQPSTQLSNLG
CCCCCCCCHHHHCCC
18.8021955146
187PhosphorylationSPGLQPSTQLSNLGS
CCCCCCCHHHHCCCC
39.9721955146
187UbiquitinationSPGLQPSTQLSNLGS
CCCCCCCHHHHCCCC
39.9724816145
190PhosphorylationLQPSTQLSNLGSTET
CCCCHHHHCCCCCCC
21.8630278072
191UbiquitinationQPSTQLSNLGSTETL
CCCHHHHCCCCCCCH
57.9529967540
194PhosphorylationTQLSNLGSTETLEEM
HHHHCCCCCCCHHHC
26.6625022875
195PhosphorylationQLSNLGSTETLEEMP
HHHCCCCCCCHHHCC
31.0621712546
197PhosphorylationSNLGSTETLEEMPSG
HCCCCCCCHHHCCCC
39.2925022875
198PhosphorylationNLGSTETLEEMPSGS
CCCCCCCHHHCCCCC
4.2332142685
203PhosphorylationETLEEMPSGSQDKSA
CCHHHCCCCCCCCCC
50.1720873877
205PhosphorylationLEEMPSGSQDKSAPS
HHHCCCCCCCCCCCC
39.2720873877
215UbiquitinationKSAPSGHKHLTVEEL
CCCCCCCCCEEHHHH
43.7829967540
218PhosphorylationPSGHKHLTVEELFGT
CCCCCCEEHHHHHCC
26.1228060719
225PhosphorylationTVEELFGTSLPKEQP
EHHHHHCCCCCCCCC
21.5429255136
225UbiquitinationTVEELFGTSLPKEQP
EHHHHHCCCCCCCCC
21.5424816145
226PhosphorylationVEELFGTSLPKEQPA
HHHHHCCCCCCCCCC
42.9529255136
229UbiquitinationLFGTSLPKEQPAVVG
HHCCCCCCCCCCEEC
74.4229967540
238UbiquitinationQPAVVGLDSEEMERL
CCCEECCCHHHHHCC
48.3429967540
239O-linked_GlycosylationPAVVGLDSEEMERLP
CCEECCCHHHHHCCC
40.2623301498
242PhosphorylationVGLDSEEMERLPGDA
ECCCHHHHHCCCCCC
2.9732142685
243PhosphorylationGLDSEEMERLPGDAS
CCCHHHHHCCCCCCC
55.1132142685
247PhosphorylationEEMERLPGDASQKEP
HHHHCCCCCCCCCCC
47.9432142685
274UbiquitinationGAPQSETLGVPSAAH
CCCCHHCCCCCCHHC
5.9724816145
276UbiquitinationPQSETLGVPSAAHHS
CCHHCCCCCCHHCCC
3.6829967540
277PhosphorylationQSETLGVPSAAHHSV
CHHCCCCCCHHCCCC
19.2232142685
280PhosphorylationTLGVPSAAHHSVQPE
CCCCCCHHCCCCCCC
12.7932142685
281PhosphorylationLGVPSAAHHSVQPEI
CCCCCHHCCCCCCCC
17.3032142685
289PhosphorylationHSVQPEITTPVLITP
CCCCCCCCCCEEECC
24.3226074081
290PhosphorylationSVQPEITTPVLITPA
CCCCCCCCCEEECCC
19.6326074081
295PhosphorylationITTPVLITPASITQS
CCCCEEECCCCCCCC
14.51-
308UbiquitinationQSNEKHAPTYTIPLS
CCCCCCCCEEEEECC
26.1724816145
309PhosphorylationSNEKHAPTYTIPLSP
CCCCCCCEEEEECCC
33.8029255136
310PhosphorylationNEKHAPTYTIPLSPV
CCCCCCEEEEECCCC
11.1230278072
311PhosphorylationEKHAPTYTIPLSPVL
CCCCCEEEEECCCCC
20.7129255136
315PhosphorylationPTYTIPLSPVLSPTL
CEEEEECCCCCCCCC
13.9629255136
319PhosphorylationIPLSPVLSPTLPAEA
EECCCCCCCCCCCCC
18.9729255136
321PhosphorylationLSPVLSPTLPAEAPT
CCCCCCCCCCCCCCC
41.8329255136
325UbiquitinationLSPTLPAEAPTAQVP
CCCCCCCCCCCCCCC
53.9229967540
328PhosphorylationTLPAEAPTAQVPPSL
CCCCCCCCCCCCCCC
36.4529255136
329PhosphorylationLPAEAPTAQVPPSLP
CCCCCCCCCCCCCCC
13.8132142685
334PhosphorylationPTAQVPPSLPRNSTM
CCCCCCCCCCCCCHH
44.9623927012
339PhosphorylationPPSLPRNSTMMQAVK
CCCCCCCCHHHHHHH
20.9626074081
340PhosphorylationPSLPRNSTMMQAVKT
CCCCCCCHHHHHHHC
21.8826074081
346AcetylationSTMMQAVKTTPRQRS
CHHHHHHHCCHHHCC
50.0925953088
346UbiquitinationSTMMQAVKTTPRQRS
CHHHHHHHCCHHHCC
50.0924816145
347PhosphorylationTMMQAVKTTPRQRSP
HHHHHHHCCHHHCCC
35.1228450419
348PhosphorylationMMQAVKTTPRQRSPL
HHHHHHCCHHHCCCC
15.6827422710
353PhosphorylationKTTPRQRSPLLNQPV
HCCHHHCCCCCCCCC
16.1529255136
359UbiquitinationRSPLLNQPVPELSHA
CCCCCCCCCCCCCHH
42.4229967540
361UbiquitinationPLLNQPVPELSHASL
CCCCCCCCCCCHHHH
43.4229967540
363PhosphorylationLNQPVPELSHASLIA
CCCCCCCCCHHHHHC
3.5832142685
364PhosphorylationNQPVPELSHASLIAN
CCCCCCCCHHHHHCC
18.4923927012
366PhosphorylationPVPELSHASLIANQS
CCCCCCHHHHHCCCC
11.5832142685
367PhosphorylationVPELSHASLIANQSP
CCCCCHHHHHCCCCC
18.1923927012
369PhosphorylationELSHASLIANQSPFR
CCCHHHHHCCCCCCC
2.9132142685
373PhosphorylationASLIANQSPFRAPLN
HHHHCCCCCCCCCCE
26.3025159151
376Asymmetric dimethylarginineIANQSPFRAPLNVTN
HCCCCCCCCCCEEEC
38.38-
376MethylationIANQSPFRAPLNVTN
HCCCCCCCCCCEEEC
38.3824129315
378UbiquitinationNQSPFRAPLNVTNTA
CCCCCCCCCEEECCC
21.8829967540
382PhosphorylationFRAPLNVTNTAGTSL
CCCCCEEECCCCCCC
26.2720068231
384PhosphorylationAPLNVTNTAGTSLPS
CCCEEECCCCCCCCC
19.6620068231
387PhosphorylationNVTNTAGTSLPSVDL
EEECCCCCCCCCHHH
25.3228348404
388O-linked_GlycosylationVTNTAGTSLPSVDLL
EECCCCCCCCCHHHH
37.0523301498
388PhosphorylationVTNTAGTSLPSVDLL
EECCCCCCCCCHHHH
37.0528348404
391PhosphorylationTAGTSLPSVDLLQKL
CCCCCCCCHHHHHHH
33.2920068231
397UbiquitinationPSVDLLQKLRLTPQH
CCHHHHHHHCCCCCC
35.2329967540
399UbiquitinationVDLLQKLRLTPQHDQ
HHHHHHHCCCCCCCC
43.4829967540
401PhosphorylationLLQKLRLTPQHDQIQ
HHHHHCCCCCCCCCC
17.9229255136
402PhosphorylationLQKLRLTPQHDQIQT
HHHHCCCCCCCCCCC
33.8232142685
404PhosphorylationKLRLTPQHDQIQTQP
HHCCCCCCCCCCCCC
30.1032142685
407PhosphorylationLTPQHDQIQTQPLGK
CCCCCCCCCCCCCCC
6.2732142685
409PhosphorylationPQHDQIQTQPLGKGA
CCCCCCCCCCCCCCC
33.5123927012
416UbiquitinationTQPLGKGAMVASFSP
CCCCCCCCEEEEECC
7.8629967540
420PhosphorylationGKGAMVASFSPAAGQ
CCCCEEEEECCCCCC
18.1725850435
422PhosphorylationGAMVASFSPAAGQLA
CCEEEEECCCCCCCC
15.9025159151
430PhosphorylationPAAGQLATPESFIEP
CCCCCCCCCHHHCCC
35.8625159151
433PhosphorylationGQLATPESFIEPPSK
CCCCCCHHHCCCCCH
32.5022199227
439PhosphorylationESFIEPPSKTAAARV
HHHCCCCCHHHHHHH
54.0426074081
448UbiquitinationTAAARVAASASLSNM
HHHHHHHHHHHHHHH
11.6329967540
449PhosphorylationAAARVAASASLSNMV
HHHHHHHHHHHHHHC
14.5120068231
451PhosphorylationARVAASASLSNMVLA
HHHHHHHHHHHHCHH
29.8132142685
453PhosphorylationVAASASLSNMVLAPL
HHHHHHHHHHCHHHH
22.0033259812
456PhosphorylationSASLSNMVLAPLQSM
HHHHHHHCHHHHHHH
4.8932142685
462PhosphorylationMVLAPLQSMQQNQDP
HCHHHHHHHHHCCCC
26.6620068231
465UbiquitinationAPLQSMQQNQDPEVF
HHHHHHHHCCCCCHH
40.6929967540
482UbiquitinationPKVLSSAIQVAGAPL
HHHHHHHHHHCCCCC
3.5129967540
485PhosphorylationLSSAIQVAGAPLVTA
HHHHHHHCCCCCEEE
7.6432142685
487PhosphorylationSAIQVAGAPLVTATT
HHHHHCCCCCEEECC
5.6332142685
490PhosphorylationQVAGAPLVTATTTAV
HHCCCCCEEECCHHH
3.1332142685
491O-linked_GlycosylationVAGAPLVTATTTAVS
HCCCCCEEECCHHHH
26.4323301498
493O-linked_GlycosylationGAPLVTATTTAVSSV
CCCCEEECCHHHHHH
18.4723301498
494O-linked_GlycosylationAPLVTATTTAVSSVL
CCCEEECCHHHHHHH
15.4223301498
495O-linked_GlycosylationPLVTATTTAVSSVLL
CCEEECCHHHHHHHH
22.2523301498
498O-linked_GlycosylationTATTTAVSSVLLAPS
EECCHHHHHHHHCHH
16.5623301498
499O-linked_GlycosylationATTTAVSSVLLAPSV
ECCHHHHHHHHCHHH
15.3623301498
499UbiquitinationATTTAVSSVLLAPSV
ECCHHHHHHHHCHHH
15.3629967540
515O-linked_GlycosylationQQTVTRSSDLERKAS
CCCCCCCHHHHHHCC
42.8123301498
520UbiquitinationRSSDLERKASSPSPL
CCHHHHHHCCCCCCC
43.1529967540
522PhosphorylationSDLERKASSPSPLTI
HHHHHHCCCCCCCCC
45.9029255136
523PhosphorylationDLERKASSPSPLTIG
HHHHHCCCCCCCCCC
33.9729255136
525PhosphorylationERKASSPSPLTIGTP
HHHCCCCCCCCCCCC
34.1919664994
528PhosphorylationASSPSPLTIGTPESQ
CCCCCCCCCCCCHHH
22.2729255136
531PhosphorylationPSPLTIGTPESQRKP
CCCCCCCCCHHHCCC
21.7419664994
534PhosphorylationLTIGTPESQRKPSII
CCCCCCHHHCCCEEE
36.1730266825
537UbiquitinationGTPESQRKPSIILSK
CCCHHHCCCEEEEEH
35.1629967540
539PhosphorylationPESQRKPSIILSKSQ
CHHHCCCEEEEEHHH
25.8723882029
543PhosphorylationRKPSIILSKSQLQDT
CCCEEEEEHHHHHHH
21.6130576142
545PhosphorylationPSIILSKSQLQDTLI
CEEEEEHHHHHHHHH
32.5225159151

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
315SPhosphorylationKinaseMAPK8P45983
GPS

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of DCP1A_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of DCP1A_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
SMAD4_HUMANSMAD4physical
11836524
DCP2_HUMANDCP2physical
12417715
RENT1_HUMANUPF1physical
12417715
DDX6_HUMANDDX6physical
16364915
EDC3_HUMANEDC3physical
16364915
HS71L_HUMANHSPA1Lphysical
16364915
EDC4_HUMANEDC4physical
16364915
DCP2_HUMANDCP2physical
16364915
DCP1B_HUMANDCP1Bphysical
16364915
AASS_HUMANAASSphysical
24778252
BAG4_HUMANBAG4physical
24778252
DCP1B_HUMANDCP1Bphysical
24778252
DDX6_HUMANDDX6physical
24778252
EDC3_HUMANEDC3physical
24778252
EDC4_HUMANEDC4physical
24778252
EI2BD_HUMANEIF2B4physical
24778252
KANK2_HUMANKANK2physical
24778252
PFKAM_HUMANPFKMphysical
24778252
PNRC1_HUMANPNRC1physical
24778252
PCH2_HUMANTRIP13physical
24778252
DCP1B_HUMANDCP1Bphysical
25036637
DDX6_HUMANDDX6physical
25036637
EDC3_HUMANEDC3physical
25036637
EDC4_HUMANEDC4physical
25036637
DCP2_HUMANDCP2physical
25036637
RITA1_HUMANRITA1physical
25416956
DDX6_HUMANDDX6physical
26496610
MP2K1_HUMANMAP2K1physical
26496610
P5CS_HUMANALDH18A1physical
26496610
TBX3_HUMANTBX3physical
26496610
BAG4_HUMANBAG4physical
26496610
MARF1_HUMANKIAA0430physical
26496610
PNRC1_HUMANPNRC1physical
26496610
EDC4_HUMANEDC4physical
26496610
TRM6_HUMANTRMT6physical
26496610
EDC3_HUMANEDC3physical
26496610
DCP2_HUMANDCP2physical
26496610
PATL1_HUMANPATL1physical
26496610
PPR37_HUMANPPP1R37physical
26496610
EDC4_HUMANEDC4physical
27315556
XRN1_HUMANXRN1physical
27315556
EDC3_HUMANEDC3physical
27315556
TRAF6_HUMANTRAF6physical
27315556
DCP2_HUMANDCP2physical
27315556

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of DCP1A_HUMAN

loading...

Related Literatures of Post-Translational Modification
Phosphorylation
ReferencePubMed
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions.";
Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.;
Sci. Signal. 2:RA46-RA46(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-180; SER-315; SER-319;SER-353; SER-522; SER-523; SER-525 AND THR-531, AND MASS SPECTROMETRY.
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-522; SER-523; SER-525AND THR-531, AND MASS SPECTROMETRY.
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-142; SER-315; SER-319;SER-334; THR-401; SER-522; SER-523; SER-525 AND THR-531, AND MASSSPECTROMETRY.
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle.";
Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.;
Mol. Cell 31:438-448(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-315; SER-319; SER-353AND THR-401, AND MASS SPECTROMETRY.
"Combining protein-based IMAC, peptide-based IMAC, and MudPIT forefficient phosphoproteomic analysis.";
Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,Yates J.R. III;
J. Proteome Res. 7:1346-1351(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-315; SER-319; SER-334AND THR-531, AND MASS SPECTROMETRY.
"Automated phosphoproteome analysis for cultured cancer cells by two-dimensional nanoLC-MS using a calcined titania/C18 biphasic column.";
Imami K., Sugiyama N., Kyono Y., Tomita M., Ishihama Y.;
Anal. Sci. 24:161-166(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-525, AND MASSSPECTROMETRY.
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks.";
Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.;
Cell 127:635-648(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-353, AND MASSSPECTROMETRY.
"Large-scale characterization of HeLa cell nuclear phosphoproteins.";
Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,Li J., Cohn M.A., Cantley L.C., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-523 AND SER-525, ANDMASS SPECTROMETRY.

TOP